Hematologic and histopathologic evaluation of N-(phosphonacetyl)-L-aspartate (PALA) in mice.

Suppr

超能文献

作者信息

Harrison S D, Giles H D, Denine E P

出版信息

Cancer Chemother Pharmacol. 1979;2(3):183-7. doi: 10.1007/BF00258293.

DOI:10.1007/BF00258293

PMID:455573

Abstract

摘要

相似文献

Hematologic and histopathologic evaluation of N-(phosphonacetyl)-L-aspartate (PALA) in mice.

Cancer Chemother Pharmacol. 1979;2(3):183-7. doi: 10.1007/BF00258293.

Phase I trial of N-(Phosphonacetyl)-L-aspartic acid (PALA).N-（膦酰乙酰基）-L-天冬氨酸（PALA）的I期试验。

Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1067-71.

Effects of N-(phosphonacetyl)-L-aspartate on murine tumors and normal tissues in vivo and in vitro and the relationship of sensitivity to rate of proliferation and level of aspartate transcarbamylase.N-（膦酰基乙酰基）-L-天冬氨酸对小鼠肿瘤及正常组织的体内外作用以及敏感性与增殖速率和天冬氨酸转氨甲酰酶水平的关系

Cancer Res. 1978 Feb;38(2):371-8.

Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA).

Cancer Treat Rep. 1980 Feb-Mar;64(2-3):285-92.

Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA).抗肿瘤药物N-（膦酰乙酰基）-L-天冬氨酸（PALA）的酶活性测定

Cancer Treat Rep. 1979 Jan;63(1):85-8.

Determination of N-(phosphonacetyl)-L-aspartic acid (PALA) in plasma and urine by high pressure liquid chromatography.用高压液相色谱法测定血浆和尿液中的N-（膦酰基乙酰基）-L-天冬氨酸（PALA）

Eur J Cancer (1965). 1980 Nov;16(11):1483-7. doi: 10.1016/0014-2964(80)90059-6.

Phase I study of N-(phosphonacetyl)-L-aspartic acid (PALA).N-（膦酰基乙酰基）-L-天冬氨酸（PALA）的I期研究。

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1909-12.

Long-term association of N-(phosphonacetyl)-L-aspartate with bone.N-（膦酰基乙酰基）-L-天冬氨酸与骨骼的长期关联。

Cancer Res. 1981 Jan;41(1):150-6.

A facile enzymatic technique for the estimation of nanomolar concentrations of N-phosphonacetyl-L-aspartic acid in plasma.

J Biochem Biophys Methods. 1980 Jan-Feb;2(1):29-35. doi: 10.1016/0165-022x(80)90071-8.

Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activity.外周血白细胞作为N-（膦酰基乙酰基）-L-天冬氨酸（PALA）对人L-天冬氨酸转氨甲酰酶（ATCase）活性的酶促作用指标。

Cancer Treat Rep. 1980 Aug-Sep;64(8-9):967-73.

引用本文的文献

Antitumor drug toxicity in tumor-free and tumor-bearing mice.无瘤和荷瘤小鼠的抗肿瘤药物毒性。

Cancer Chemother Pharmacol. 1980;4(3):199-204. doi: 10.1007/BF00254019.

本文引用的文献

Toxicity studies in mice treated with 1-beta-D-arabinofuranosylcytosine (ara-C).

Cancer Res. 1969 Mar;29(3):529-35.

Aspartate transcarbamylase. Interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate.天冬氨酸转氨甲酰酶。与过渡态类似物N-（膦酰乙酰基）-L-天冬氨酸的相互作用。

J Biol Chem. 1971 Nov;246(21):6599-605.

Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.天冬氨酸转氨甲酰酶的过渡态抑制剂N-（膦酰乙酰基）-L-天冬氨酸的抗肿瘤活性

Cancer Res. 1976 Aug;36(8):2720-5.

Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.

Cancer Treat Rep. 1977 May-Jun;61(3):409-17.

Hematology and clinical chemistry reference values for C57BL/6 X DBA/2 F1 mice.C57BL/6 X DBA/2 F1小鼠的血液学和临床化学参考值。

Cancer Res. 1978 Aug;38(8):2636-9.

Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF mice.

Cancer Treat Rep. 1978 Apr;62(4):533-45.

Cancer Res. 1978 Feb;38(2):371-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验